Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014

被引:94
|
作者
Zghebi, Salwa S. [1 ,2 ]
Steinke, Douglas T. [1 ]
Carr, Matthew J. [3 ]
Rutter, Martin K. [4 ,5 ]
Emsley, Richard A. [6 ]
Ashcroft, Darren M. [1 ]
机构
[1] Univ Manchester, Ctr Pharmacoepidemiol & Drug Safety, Div Pharm & Optometry, Sch Hlth Sci,Fac Biol Med & Hlth,MAHSC, Manchester, Lancs, England
[2] Univ Tripoli, Dept Pharmaceut, Fac Pharm, Tripoli, Libya
[3] Univ Manchester, Div Psychol & Mental Hlth, Sch Hlth Sci, Fac Biol Med & Hlth, Manchester, Lancs, England
[4] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England
[5] Cent Manchester Univ Hosp NHS Fdn Trust, MAHSC, Manchester Diabet Ctr, Manchester, Lancs, England
[6] Univ Manchester, Fac Biol Med & Hlth, Div Populat Hlth Hlth Serv Res & Primary Care, Ctr Biostat,Sch Hlth Sci,MAHSC, Manchester, Lancs, England
来源
DIABETES OBESITY & METABOLISM | 2017年 / 19卷 / 11期
关键词
CPRD; database research; incidence; prevalence; primary care; type; 2; diabetes; WEIGHT-LOSS; 3.0; MG; LIRAGLUTIDE; OBESITY; DEPRESSION; OVERWEIGHT; EFFICACY; DISORDERS; SAFETY; INDIVIDUALS;
D O I
10.1111/dom.12964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Contemporary data describing type 2 diabetes prevalence, incidence and mortality are limited. We aimed to (1) estimate annual incidence and prevalence rates of type 2 diabetes in the UK between 2004 and 2014, (2) examine relationships between observed rates with age, gender, socio-economic status and geographic region, and (3) assess how temporal changes in incidence and all-cause mortality rates influence changes in prevalence. Methods: Type 2 diabetes patients aged >= 16 years between January 2004 and December 2014 were identified using the Clinical Practice Research Datalink (CPRD). Up to 5 individuals without diabetes were matched to diabetes patients based on age, gender and the general practice. Annual incidence, prevalence and mortality rates were calculated per 10 000 personyears at risk (95% CI). Survival models compared mortality rates in patients with and without type 2 diabetes. Results: Prevalence rates of type 2 diabetes increased from 3.21% (3.19; 3.22) in 2004 to 5.26% (5.24; 5.29) in 2014. Incidence rates remained stable, overall, throughout the study period. Higher incidence and prevalence rates were related to male gender and deprivation. Individuals with type 2 diabetes were associated with higher risk of mortality (Hazard ratio 1.26 [1.20; 1.32]). Mortality rates declined in patients with and without diabetes throughout the study period. The incidence and prevalence of type 2 diabetes in patients aged 16 to 34 years increased over time. Conclusions: The rising prevalence of type 2 diabetes in the UK over the last decade is probably explained by patients living longer rather than by increasing incidence of type 2 diabetes.
引用
收藏
页码:1537 / 1545
页数:9
相关论文
共 50 条
  • [1] Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013
    Read, Stephanie H.
    Kerssens, Joannes J.
    McAllister, David A.
    Colhoun, Helen M.
    Fischbacher, Colin M.
    Lindsay, Robert S.
    McCrimmon, Rory J.
    McKnight, John A.
    Petrie, John R.
    Sattar, Naveed
    Wild, Sarah H.
    [J]. DIABETOLOGIA, 2016, 59 (10) : 2106 - 2113
  • [2] Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013
    Stephanie H. Read
    Joannes J. Kerssens
    David A. McAllister
    Helen M. Colhoun
    Colin M. Fischbacher
    Robert S. Lindsay
    Rory J. McCrimmon
    John A. McKnight
    John R. Petrie
    Naveed Sattar
    Sarah H. Wild
    [J]. Diabetologia, 2016, 59 : 2106 - 2113
  • [3] Erratum to: Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013
    Stephanie H. Read
    Joannes J. Kerssens
    David A. McAllister
    Helen M. Colhoun
    Colin M. Fischbacher
    Robert S. Lindsay
    Rory J. McCrimmon
    John A. McKnight
    John R. Petrie
    Naveed Sattar
    Sarah H. Wild
    [J]. Diabetologia, 2016, 59 : 2492 - 2492
  • [4] Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020
    Overbeek, Jetty A.
    Nijpels, Giel
    Swart, Karin M. A.
    Blom, Marieke
    Elders, Petra J. M.
    Herings, Ron M. C.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 1503 - 1509
  • [5] Type 2 diabetes, the epidemic: Trends in incidence and prevalence, 2004-2020
    Overbeek, Jetty A.
    Nijpels, Giel
    Swart, Karin M. A.
    Blom, Marieke T.
    Elders, Petra J. M.
    Herings, Ron M. C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 225 - 225
  • [6] Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013 (vol 59, pg 2492, 2016)
    Read, Stephanie H.
    Kerssens, Joannes J.
    McAllister, David A.
    Colhoun, Helen M.
    Fischbacher, Colin M.
    Lindsay, Robert S.
    McCrimmon, Rory J.
    McKnight, John A.
    Petrie, John R.
    Sattar, Naveed
    Wild, Sarah H.
    [J]. DIABETOLOGIA, 2016, 59 (11) : 2492 - 2492
  • [7] Trends in prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996-2016
    Carstensen, B.
    Ronn, P. F.
    Jorgensen, M. E.
    [J]. DIABETOLOGIA, 2018, 61 : S64 - S64
  • [8] Trends in Incidence and Prevalence of Type 2 Diabetes in the United Kingdom (2004-2014) Using the Clinical Practice Research Datalink (CPRD)
    Zghebi, Salwa S.
    Steinke, Douglas T.
    Carr, Matthew J.
    Ashcroft, Darren M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 75 - 76
  • [9] Trends in Incidence, Prevalence, and Management of Type 2 Diabetes in Hungary from 2001-2014
    Jermendy, Gyorgy
    Kiss, Zoltan
    Rokszin, Gyorgy
    Abonyi-Toth, Zsolt
    Wittmann, Istvan
    Kempler, Peter
    [J]. DIABETES, 2017, 66 : A450 - A450
  • [10] Trends In Incidence, Prevalence And Prescribing In Type 2 Diabetes Mellitus
    Sharma, Manuj
    Nazareth, Irwin
    Petersen, Irene
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 24 - 25